Showing results (81-90 of 136) with videos related to

Sort By:
Pageof 14
British Journal of Haematology|July 9, 2013
Low-dose anti-CD20 veltuzumab given intravenously or subcutaneously is active in relapsed immune thrombocytopenia: a phase I studyHoward A Liebman, Mansoor N Saleh, James B Bussel, et al.
Journal of Molecular Biology|July 16, 2003
Probing the sensory rhodopsin II binding domain of its cognate transducer by calorimetry and electrophysiologySilke Hippler-Mreyen, Johann P Klare, Ansgar A Wegener, et al.
Journal of Pediatric Surgery|September 11, 2004
Diagnosing suspected acute nonclassic appendicitis with sulesomab, a radiolabeled antigranulocyte antibody imaging agentAnthony M Passalaqua, Robert L Klein, William A Wegener, et al.
Experimental and Clinical Psychopharmacology|December 2, 2004
Delay discounting of potentially real and hypothetical rewards: II. Between- and within-subject comparisonsGregory J Madden, Bethany R Raiff, Carla H Lagorio, et al.
Cancer|February 4, 2010
Three methods assessing red marrow dosimetry in lymphoma patients treated with radioimmunotherapyLudovic Ferrer, Françoise Kraeber-Bodéré, Caroline Bodet-Milin, et al.
JAMA Dermatology|August 19, 2014
Subcutaneous veltuzumab, a humanized anti-CD20 antibody, in the treatment of refractory pemphigus vulgarisChristoph T Ellebrecht, Eun J Choi, David M Allman, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|October 6, 2021
Adolescent Dopamine Neurons Represent Reward Differently during Action and State Guided LearningAqilah M McCane, Meredyth A Wegener, Mojdeh Faraji, et al.
Pageof 14